MetLife Adds Boston Life Science Asset for $103M
MetLife Investment Management has completed its $103 million purchase of Burlington BioCenter, a 109,085-square-foot life science research and pharmaceutical manufacturing facility in Burlington, Mass. Public records show MetLife financed the acquisition with a $54.4 million loan from Northwestern Mutual. Newmark represented the seller, a joint venture between The Gutierrez Company and GEM Realty Capital, and procured the buyer. The partnership had […]